Google and 15 Stocks Making Deal Buzz This Week

Here’s your Cheat Sheet to this week’s top mergers and acquisition news:

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

The Blackstone Group (NYSE:BX): Current price $20.83

Blackstone and its Brazilian partner Patria Investimentos Ltda. will acquire an interest in that country’s biggest residential land developer, gambling that the appeal of its gated communities will survive a slump in home prices. The firms will purchase 70 percent of Gafisa’s Alphaville Urbanismo residential development business at $651 million. The transaction is the first real estate deal to emerge from Blackstone’s 2010 investment in Patria, as it banks on increasing demand for housing and Alphaville’s brand enticing buyers as Brazil’s home-price growth eases.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

BX

Smithfield Foods (NYSE:SFD): Current price $32.80

Some extremely old statutes that disallow foreign ownership of farmland in Iowa, Missouri, and other Midwest states could complicate Shuanghui International’s $4.7-billion planned acquisition of the pork major. The transaction would be the largest buy in the United States by a Chinese firm, and will be examined by a federal government panel that assesses national security risks, but that should not block the sale. Some politicians have raised fears in regards to food safety, and farmers groups are dubious concerning consolidation and potential damage to small farmers. The land laws could be employed by those who oppose the deal and at a minimum could lead to complex legal maneuvering by the parties.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

SFD

AstraZeneca Group (NYSE:AZN): Current price $50.80

AstraZeneca said on Monday that it is acquiring the privately held firm Pearl Therapeutics, which focuses on the development of inhaled small-molecule therapeutics for respiratory disease, at a price up to $1.15 billion. AstraZeneca will buy the entirety of Pearl’s shares for initial consideration of $560 million payable on completion. Deferred consideration of as much as $450 million becomes payable on achievement of specified development and regulatory milestones in respect of any triple combination therapies and selected future products that AstraZeneca develops employing Pearl’s tech platform. The transaction should close in the third quarter.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

AZN

The Travelers Companies (NYSE:TRV): Current price $82.25

On Monday, Travelers said that it will acquire The Dominion of Canada General Insurance Company from E-L Financial Corporation Limited, for roughly $1.1 billion in cash, subject to adjustment. The Dominion and Travelers Canadian operations will be joined, and the combined entity will remain headquartered in Toronto. The deal should close in the fourth quarter.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

TRV

Don’t Miss: Will Plug-In Vehicles Win the Long Game?

Google (NASDAQ:GOOG): Current price $875.20

Tuesday on its website, Google announced the official closing on its acquisition of the Israeli traffic update firm Waze. For the time being, the Waze product development team will stay in Israel and operate separately. Google said in its blog, “We’re excited about the prospect of enhancing Google Maps with some of the traffic update features provided by Waze and enhancing Waze with Google’s search capabilities. We’ll also work closely with the vibrant Waze community, who are the DNA of this app, to ensure they have what’s needed to grow and prosper. The Waze community and its dedicated team have created a great source of timely road corrections and updates. We welcome them to Google and look forward to working with them in our ongoing effort to make a comprehensive, accurate and useful map of the world.”

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

GOOG

Salesforce.com (NYSE:CRM): Current price $37.40

The cloud-computing firm Salesforce.com stays on its shopping binge, as late last week it snapped up EdgeSpring, which builds business-intelligence and analytics software Financials of the transaction were not reported. Salesforce was quite discreet with the EdgeSpring compared to its $2.5-billion ExactTarget purchase, also last week, that included the typical hoopla: a conference call, a press release with plenty of executive quotes, and more. In a conference call on June 4 with analysts and journalists, Salesforce Chief Executive Marc Benioff implied that the firm would take “a vacation from M&A for anywhere between probably 12 and 18 months.”

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

CRM

DISH Network Corp. (NASDAQ:DISH): Current price $39.35

Knowledgeable sources say that the merger discussions with Sprint Nextel Corporation (NYSE:Swent awry partly about Sprint insisting on a $3 billion reverse breakup fee in case the deal did win approval. Rather, Dish had proposed a $1 billion termination fee, said the sources. Sprint announced Monday that Dish had not come up with an “actionable” bid, and moved instead to endorse a sweetened, $21.6 billion offer from SoftBank Corp., which originally agreed to buy the carrier back in October.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

DISH

The Hertz Corporation (NYSE: HTZ): Current price $24.43

Hertz Corp. says that Hertz UK Limited has purchased CCL Vehicle Rentals, a national accident management provider headquartered in Dorset, England. The acquisition positions Hertz for hefty growth potential in the £1-billion car and van insurance replacement market in the United Kingdom. Beyond that, Hertz builds upon its impressive track record of success in the United States, where it has participated in the insurance replacement industry for more than 10 years.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

HTZ

Investing Insights: Is Kraft Expensive or Undervalued?

Yahoo! (NASDAQ:YHOO): Current price $26.27

Yahoo quickly follows up its acquisition of the iOS photo app maker GhostBird Software, by snapping up the six-year-old free conference calling service Rondee, for an unreported amount. The latter’s website now reads that after June 30, users will no longer be permitted access to their data or create new conference calls. Beyond that, the startup will continue its shut down from that point, officially ceasing operations on July 12, prior to ultimately cutting off user access to their calling data on July 30, according to an email to its customers Thursday.

Are these stocks a buy or sell? Let us help you decide.

Check out our Stock Picker Newsletter now.

YHOO

DIRECTV (NASDAQ:DTV): Current price $62

Knowledgeable sources according to PandoDaily say of the ongoing Hulu acquisition talks that a deal is imminent and that DIRECTV will likely prevail, and that the acquisition price will have a “B” in it. Hulu’s owners have been openly searching out a suitor for the premium streaming video-on-demand platform, and during the past several months reports have emerged telling of offers from DirecTV,  KKR, Time Warner Cable, Yahoo!, Guggenheim Digital, The Chernin Group in partnership with AT&T, and Silverlake Partners in partnership with William Morris Endeavor Entertainment. If that is not sufficiently complex, the company is also being advised by Guggenheim Partners, which is a sister company to Guggenheim Digital.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

DTV

Life Technologies Corporation (NASDAQ:LIFE): Current price $74.15

On Thursday, Life Technologies said that it will purchase the instrument distributor Life Science Korea, based in Seoul. The latter has been Life Technologies’ primary instrument distributor since 1994, and it holds distribution rights to Applied Biosystems products, such as Sanger sequencing systems, next-generation sequencing instruments, forensics, and PCR products.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

LIFE

Royal Bank of Canada (NYSE:RY): Current price $58.94

Royal Bank of Canada’s Chief Financial Office Janice Fukakusa reported at the Morgan Stanley U.S. Financials Conference in New York that the company could make wealth management purchases valued as much as $5 billion, explaining that the bank expects to add capacity in asset management on the equity side, “given where the fixed-income cycle is. We’re not betting the bank, so they would be bite-sized (deals). I would say maybe it’s $1 (billion) to $3-$5 billion.”

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

RY

Don’t Miss: Is Business Optimism Flagging Thanks to Weaker Sales?

Sprint Nextel Corporation (NYSE:S): Current price $7.30

The SoftBank Corp. Chief Executive Masayoshi Son wants his company to move into the into the United States wireless market, as it is attempting to acquire Sprint. Should that come to failure though, Son says that he views T-Mobile US as a “Plan B” purchase target, remarking to a Bloomberg reporter in Tokyo Friday, “I plan to go with Plan A if possible,” in reference to the SoftBank’s October agreement to acquire Sprint. This week, Son boosted his bid for Sprint to $21.6 billion, intending to resist a counteroffer from DISH Network Corp. Son is said to be relying upon Sprint, the number three domestic wireless carrier, to energize his international expansion, if he can get past his billionaire Charlie Ergen, who is the chairman and co-founder of Dish, and wants to utilize Sprint to catapult his satellite-TV firm into mobile-phone services.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

S

F.N.B. Corporation (NYSE: FNB): Current price $11.09

F.N.B. Corporation will acquire BCSB Bancorp (NASDAQ:BCSB), which is the parent of Baltimore County Savings Bank, in an all-stock transaction valued at about $23.77 per share, or a total of $79 million, calculated upon the close of F.N.B. as of Thursday. This acquisition should provide the buyer with an additional $640 million in total assets, among which include $560 million in aggregate deposits, $320 million in loans, and 16 banking offices in the greater Baltimore area.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

FNB

Elan Corporation (NYSE:ELN): Current price $13.68

Royalty Pharma’s Chief Executive Pablo Legorreta says that he believes that the sole reason Elan Corporation announced that a sales process is moving forward is to turn aside Royalty’s own offer, according to a statement released Friday morning. Royalty has not been contacted by Elan or its financial advisers, Legorreta said in the e-mailed statement, which continued that ”If shareholders want to have the option to choose between Royalty Pharma’s  offer or a sale process, they should vote against all four of Elan’s proposals,  especially the share repurchase program.”

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

ELN

Mindray Medical International (NYSE: MR): Current price $39.54

Mindray Medical will acquire the ultrasound tech firm ZONARE Medical Systems for $105 million. The buyer’s management believes that the deal will reinforce its high-end ultrasound research and development, together with its domestic sales capabilities, augmenting the firm’s goal of becoming a top provider of high-quality imaging products to markets on a global basis. The total 2012 revenues for ZONARE came to around $64 million. Mindray anticipates that the deal will be slightly dilutive to its full-year 2013 and 2014 earnings.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

MR

Don’t Miss: Do Top U.S. Executives Believe A ‘Recovery’ is Taking Place?